Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes

被引:5
|
作者
Micek, Hannah M. [1 ]
Rosenstock, Lauren [1 ]
Ma, Yicheng [1 ]
Hielsberg, Caitlin [1 ]
Montemorano, Lauren [2 ]
Gari, Metti K. [3 ,4 ]
Ponik, Suzanne M. [4 ,5 ]
Kreeger, Pamela K. [1 ,2 ,4 ,5 ]
机构
[1] Univ Wisconsin Madison, Dept Biomed Engn, Madison, WI 53705 USA
[2] Univ Wisconsin, Dept Obstet & Gynecol, Sch Med & Publ Hlth, Madison, WI 53705 USA
[3] Univ Wisconsin, Mol & Cellular Pharmacol Training Program, Sch Med & Publ Hlth, Madison, WI 53705 USA
[4] Univ Wisconsin, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth, Madison, WI 53705 USA
[5] Univ Wisconsin, Carbone Canc Ctr, Sch Med & Publ Hlth, Madison, WI 53705 USA
关键词
EXTRACELLULAR-MATRIX; MESOTHELIAL CELLS; ADHESION; EXPRESSION; ASCITES;
D O I
10.1063/5.0132254
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
High-grade serous ovarian cancer (HGSOC) metastasizes through transcoelomic spread, with both single cells and spheroids of tumor cells observed in patient ascites. These spheroids may form through single cells that detach and aggregate (Sph-SC) or through collective detachment (Sph-CD). We developed an in vitro model to generate and separate Sph-SC from Sph-CD to enable study of Sph-CD in disease progression. In vitro-generated Sph-CD and spheroids isolated from ascites were similar in size (mean diameter 51 vs 55 mu m, p > 0.05) and incorporated multiple ECM proteins. Using the in vitro model, nascent protein labeling, and qRT-PCR, we determined that ECM was produced after detachment. As fibronectin plays a key role in many cell adhesion events, we confirmed that inhibiting RGD-based adhesion or fibronectin assembly reduced Sph-CD-mesothelial adhesion strength under shear stress. Our model will enable future studies to determine factors that favor formation of Sph-CD, as well as allow investigators to manipulate Sph-CD to better study their effects on HGSOC progression.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
    Tadic, Vanja
    Zhang, Wei
    Brozovic, Anamaria
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (01):
  • [32] CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
    Turcotte, Martin
    Spring, Kathleen
    Pommey, Sandra
    Chouinard, Guillaume
    Cousineau, Isabelle
    George, Joshy
    Chen, Gregory M.
    Gendoo, Deena M. A.
    Haibe-Kains, Benjamin
    Karn, Thomas
    Rahimi, Kurosh
    Le Page, Cecile
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Stagg, John
    CANCER RESEARCH, 2015, 75 (21) : 4494 - 4503
  • [33] The Prognostic Role of BRD4 Expression in High-Grade Serous Ovarian Cancer
    Andrikopoulou, Angeliki
    Bletsa, Garyfalia
    Rouvalis, Angeliki
    Tsakogiannis, Dimitris
    Kaparelou, Maria
    Papatheodoridi, Alkistis
    Haidopoulos, Dimitrios
    Liontos, Michalis
    Dimopoulos, Meletios-Athanasios
    Zagouri, Flora
    CANCERS, 2024, 16 (11)
  • [34] Exploring the Control of PARP1 Levels in High-Grade Serous Ovarian Cancer
    Raspaglio, Giuseppina
    Buttarelli, Marianna
    Cappoli, Natalia
    Ciucci, Alessandra
    Fagotti, Anna
    Scambia, Giovanni
    Gallo, Daniela
    CANCERS, 2023, 15 (08)
  • [35] Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer
    Shen, Yen Ting
    Wang, Lucy
    Evans, James C.
    Allen, Christine
    Piquette-Miller, Micheline
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [36] A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development
    Lawrenson, Kate
    Fonseca, Marcos A. S.
    Liu, Annie Y.
    Dezem, Felipe Segato
    Lee, Janet M.
    Lin, Xianzhi
    Corona, Rosario I.
    Abbasi, Forough
    Vavra, Kevin C.
    Dinh, Huy Q.
    Gill, Navjot Kaur
    Seo, Ji-Heui
    Coetzee, Simon
    Lin, Yvonne G.
    Pejovic, Tanja
    Mhawech-Fauceglia, Paulette
    Rowat, Amy C.
    Drapkin, Ronny
    Karlan, Beth Y.
    Hazelett, Dennis J.
    Freedman, Matthew L.
    Gayther, Simon A.
    Noushmehr, Houtan
    CELL REPORTS, 2019, 29 (11): : 3726 - +
  • [37] Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma
    Peres, Lauren C.
    Colin-Leitzinger, Christelle
    Sinha, Sweta
    Marks, Jeffrey R.
    Conejo-Garcia, Jose R.
    Alberg, Anthony J.
    Bandera, Elisa, V
    Berchuck, Andrew
    Bondy, Melissa L.
    Christensen, Brock C.
    Cote, Michele L.
    Doherty, Jennifer Anne
    Moorman, Patricia G.
    Peters, Edward S.
    Segura, Carlos Moran
    Nguyen, Jonathan, V
    Schwartz, Ann G.
    Terry, Paul D.
    Wilson, Christopher M.
    Fridley, Brooke L.
    Schildkraut, Joellen M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (05) : 1006 - 1016
  • [38] The endothelin-1-driven tumor-stroma feed-forward loops in high-grade serous ovarian cancer
    Tocci, Piera
    Roman, Celia
    Sestito, Rosanna
    Caprara, Valentina
    Sacconi, Andrea
    Molineris, Ivan
    Tonon, Giovanni
    Blandino, Giovanni
    Bagnato, Anna
    CLINICAL SCIENCE, 2024, 138 (14) : 851 - 862
  • [39] Tumor Hypomethylation at 6p21.3 Associates with Longer Time to Recurrence of High-Grade Serous Epithelial Ovarian Cancer
    Wang, Chen
    Cicek, Mine S.
    Charbonneau, Bridget
    Kalli, Kimberly R.
    Armasu, Sebastian M.
    Larson, Melissa C.
    Konecny, Gottfried E.
    Winterhoff, Boris
    Fan, Jian-Bing
    Bibikova, Marina
    Chien, Jeremy
    Shridhar, Viji
    Block, Matthew S.
    Hartmann, Lynn C.
    Visscher, Daniel W.
    Cunningham, Julie M.
    Knutson, Keith L.
    Fridley, Brooke L.
    Goode, Ellen L.
    CANCER RESEARCH, 2014, 74 (11) : 3084 - 3091
  • [40] Identification of lncRNA-associated ceRNA network in high-grade serous ovarian cancer metastasis
    Li, Xi
    Yu, Sihui
    Yang, Rui
    Wang, Qi
    Liu, Xiangnan
    Ma, Mingjun
    Li, Yanli
    Wu, Sufang
    EPIGENOMICS, 2020, 12 (14) : 1175 - 1191